Literature DB >> 28591549

Prevalence and correlates of condom use among sexually active men who have sex with men in the United States: findings from the National Survey of Family Growth, 2002, 2006-10 and 2011-13.

Winston E Abara1, Emeka Oraka2, William L Jeffries Iv1, Pollyanna Chavez1, Muazzam Nasrullah1, Elizabeth DiNenno1.   

Abstract

BACKGROUND: Men who have sex with men (MSM) are disproportionately at risk of contracting HIV and other sexually transmissible infections (STIs). Correct and consistent condom use is the most effective method to prevent HIV and other STIs among sexually active MSM.
METHODS: Using data from the 2002, 2006-10, 2011-13 cycles of the National Survey of Family Growth (NSFG), the overall prevalence of condom use at last sex and by sexual risk behaviours (sex with ≥2 same-sex partners, sex with ≥2 opposite sex partners, sex with a person who injects drugs, sex with an HIV-positive person and exchanged sex for money or drugs) among sexually active MSM (reported oral or anal sex with a male in the preceding 12 months) was estimated. The association between condom use at last sex and demographic and sexual behaviour variables was also evaluated.
RESULTS: Approximately 31% of all respondents (n=618; weighted n=1596702) reported condom use at last sex. Among MSM who reported ≥1 sexual risk behaviour in the past year, prevalence of condom use at last sex ranged from 30 to 38%. After adjusting for covariates, Hispanic MSM [adjusted prevalence ratio (APR)=1.81, 95%CI=1.27-2.58] were more likely than White MSM to report condom use at last sex; MSM with a recently diagnosed STI (APR=1.71, 95%CI=1.04-2.80) were more likely than MSM without a recently diagnosed STI to report condom use at last sex; and married or cohabitating MSM (APR=0.29, 95%CI=0.13-0.66) were less likely than unmarried and not cohabitating MSM to report condom use at last sex. There was no difference in temporal trends in condom use at last sex across the three NSFG cycles [2002 (33.8%); 2006-10 (25.6%); 2011-13 (40.6%), P=0.926].
CONCLUSIONS: This study data suggest that prevalence of condom use among MSM is low, even among MSM who report sexual risk behaviours. The continued promotion of consistent condom use as an effective primary HIV/STI risk-reduction strategy is important because it mitigates HIV and STI risk and also complements the effectiveness of newer HIV prevention approaches such as pre-exposure prophylaxis.

Entities:  

Mesh:

Year:  2017        PMID: 28591549     DOI: 10.1071/SH16034

Source DB:  PubMed          Journal:  Sex Health        ISSN: 1448-5028            Impact factor:   2.706


  5 in total

1.  Awareness and Perceived Accuracy of Undetectable = Untransmittable: A Cross-Sectional Analysis With Implications for Treatment as Prevention Among Young Men Who Have Sex With Men.

Authors:  Steven Meanley; Daniel Connochie; Stephen Bonett; Dalmacio D Flores; José A Bauermeister
Journal:  Sex Transm Dis       Date:  2019-11       Impact factor: 2.830

2.  Characteristics of Sex Events, Partners, and Motivations and Their Associations with HIV-Risk Behavior in a Daily Diary Study of High-Risk Men Who Have Sex with Men (MSM).

Authors:  Tyler B Wray; Peter M Monti
Journal:  AIDS Behav       Date:  2020-06

3.  Condom Use Consistency and Associated Factors Among College Student Men Who Have Sex with Men from Seven Colleges in Changsha City: A Cross-Sectional Survey.

Authors:  Honghong Wang; Simin Yu; Wendy Cross; Louisa Lam; Biswajit Banik; Kaili Zhang
Journal:  HIV AIDS (Auckl)       Date:  2021-05-18

4.  Condom and Substance Use at Last Sex: Differences between MSMO and MSWO High School Youth.

Authors:  Gregory Phillips; Mariah M Kalmin; Blair Turner; Dylan Felt; Rachel Marro; Paul Salamanca; Lauren B Beach
Journal:  Int J Environ Res Public Health       Date:  2018-05-15       Impact factor: 3.390

5.  Substance use and risk of HIV infection among Men who have Sex with Men in India: Analysis of National IBBS data, India.

Authors:  Pradeep Kumar; Santhakumar Aridoss; Malathi Mathiyazhakan; Ganesh Balasubramanian; Nagaraj Jaganathasamy; Manikandan Natesan; Padmapriya V M; Joseph K David; Shobini Rajan; Rajatashuvra Adhikary; Elangovan Arumugam
Journal:  Medicine (Baltimore)       Date:  2020-08-28       Impact factor: 1.817

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.